Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1991-12-13
2000-05-16
Carlson, Karen Cochrane
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
530320, 530325, 530826, C12N 700, C07K 1400
Patent
active
060636122
ABSTRACT:
The present invention describes the generation of site-directed RNA cleaving agents. These agents consist of RNA-binding proteins, or polypeptides derived thereof, which are modified to contain a moiety capable of cleaving RNA backbones. Alternatively, the agents are oligonucleotides having nuclease resistant backbones to which a moiety capable of cleaving RNA backbones has been attached. The present invention also describes a method of cleaving target RNA substrates using the cleaving agents described herein. Further, the invention describes a method for inhibiting RNA virus expression in infected cells.
REFERENCES:
Malimetal 1989 Cell 58:205-214.
Corey & Schultz, 1987 Science 238:1401.
Ebright et al. 1990 PNAS 87:2882-2886.
Weeks et al. 1990 Science 249:1281.
Arnott, S. and Selsing, E., J. Mol. Biol. 88:509-521 (1974).
Beal, P.A. and Dervan, P.B., Science 251:1360-1363 (1991).
Birg, F., et al., Nucleic Acids Res. 18(10):2901-2908 (1990).
Cazenave, C., et al., Nucleic Acids Res. 15(24):10507-10521 (1987).
Chen, F.-M., Biochem. 30:4472-4479 (1991).
Cooney, M., et al., Science 241:456-459 (1988).
Cross, S., et al., Cell 49:47-56 (1987).
DeWet, J.R., et al., Mol. and Cell. Biol. 7(2):725-737 (1987).
Durand, D.B., et al., Mol. and Cell. Biol. 8(2):1715-1724 (1988).
Francois, J.-C., et al., Nucleic Acids Res. 16(24):11431-11440 (1988).
Francois, J.-C. et al., Proc. Natl. Acad. Sci. USA 86:9702-9706 (1989).
Francois, J.-C., et al., Biochem. 28:9617-9619 (1989).
Gorman, C., et al., Mol. and Cell. Biol. 2(9):1044-1051 (1982).
Griffin, L.C., and Dervan, P.B., Science 245:967-971 (1989).
Haner, R., and Dervan, P.B., Biochem. 29(42,.9762-9765 (1990).
Hanvey, J.C., et al., Nucleic Acids Res. 18(1):157 (1989).
Hausheer, F.H., et al., Anti-Cancer Drug Design 5:159-167 (1990).
Helene, C., and Thoung, N.T., Genome 31:413-421 (1989).
Helene, C., and Toulme, J.-J., Biochim. et Biophys. Acta 1049:99-125 (1990).
Horne, D.A., and Dervan, P.B., J. Am. Chem. Soc. 112:2435-2437 (1990).
Kohwi, Y., and Kohwi-Shigematsu, T., Proc. Natl. Acad. Sci. USA 85:3781-3785 (1988).
Kohwi-Shigematsu, T., and Kohwi, Y., Nucleic Acids Res. 19(15):4267-4271 (1991).
Letai, A.G., et al., Biochem. 27:9108-9112 (1988).
Lyamichev, V.I., et al., Nature 344:568 (1990).
Maher III, L.J., et al., Science 245:725-730 (1989).
Manzini, G., et al., J. Mol. Biol. 213:833-843 (1990).
Mergny, J.-L., et al., Biochem. 30(40):9791-9798 (1991).
Mirkin, S.M., et al., Nature 330:495 (1987).
Moffat, A., Science 252:1374 (1991).
Moser, H.E., and Dervan, P.B., Science 238:645-650 (1987).
Ono, A., et al., Biochem. 30:9914-9921 (1991).
Orson, F.M., et al., Nucleic Acids Res. 19(12):3435 (1991).
Pei, D., et al., Science 253:1408 (1991).
Perrouault, L., et al., Nature 344:358 (1990).
Pilch, D.S., et al., Proc. Natl. Acad. Sci. USA 87:1942-1946 (1990).
Plum, G.E., et al., Proc. Natl. Acad. Sci. USA 87:9436-9440 (1990).
Postel, E.H., et al., Proc. Natl. Acad. Sci. USA 88:8227-8231 (1991).
Praseuth, D., et al., Proc. Natl. Acad. Sci. USA 85:1349-1353 (1988).
Radhakrishnan, I., et al., Biochem. 30(87):9022-9030 (1991).
Radhakrishnan, I., et al., J. Mol. Biol. 221:1403-1418 (1991).
Rajagopal, P., and Feigon, J., Nature 339:637 (1989).
Roberts, R.W., and Crothers, D.M., Proc. Natl. Acad. Sci. USA 88:9397-9401 (1991).
Shaw, J.-P., et al., Science 241:202 (1988).
Siekevitz, M., et al., Proc. Natl. Acad. Sci. USA 84:5389-5393 (1987).
Strobel, S.A., and Dervan, P.B., Nature 35:172-174 (1991).
Sun, J.-S., et al., Proc. Natl. Acad. Sci. USA 86:9198-9202 (1989).
Williams, T., et al., J. Immunol. 141(2):652-666 (1988).
Young, S.L., et al., Proc. Natl. Acad. Sci. USA 88:10023-10026 (1991).
Jayasena Sumedha D.
Johnston Brian H.
Carlson Karen Cochrane
Fabian Gary R.
SRI - International
LandOfFree
Antiviral reagents based on RNA-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral reagents based on RNA-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral reagents based on RNA-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-257967